METHODICAL APPROACHES TO COLLECTING AND ANALYZING THE EXHALED BREATH CONDENSATE
Currently, one of the promising non-invasive diagnostic methods in pulmonology, cardiology, endocrinology, oncology is the study of the exhaled breath condensate (EBC). A significant limitation of the study of EBC in clinical practice is the absence of generally accepted standards for its collection and study of the content of biological substances containing ultra low concentrations in it. The growing scientific and practical interest in this issue led to the organization of the target group American Thoracic Society and the European Respiratory Society and the development of recommendations for the collection of condensate. We have studied and analyzed the recommendations of ATS / ERS and developed an algorithm for sampling EBC.
2. Liang Y, Yeligar SM, Brown LAS Exhaled breath condensate: a promising source for biomarkers of lung disease. The Scientific World J. 2012. Article ID 217518: 7 p. http://dx.doi.org/10.1100/2012/217518
3. Ahmadzai H, Huang S, Hettiarachchi R, Lin JL, Thomas PS, Zhang Q. Exhaled breath condensate: a comprehensive update. Clin. Chem. Lab. Med. 2013; 51(7): 1343-1361.
4. Hoffmeyer F, Raulf-Heimsoth M, Brüning T. Exhaled breath condensate and airway inflammation. Curr Opin Allergy Clin. Immunol. 2009; 9 (1): 16-22.
5. Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778-784.
6. Garey K, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest. 2004; 125: 22-26.
7. Dekhuijzen PN, Aben KKH, Dekker I, Aarts LP, Wielders PL, van Herwaarden CL. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary diseases. Am J Respir Crit Care Med. 1996; 154: 813-816.
8. Kasielski M, Nowak D. Long-term administration of N- acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Resp Med. 2001; 95: 448-456.
9. Ho LP, Faccenda J, Innes JA, Greening AP. Expired hydrogen peroxide in the breath condensate of cystic fibrosis patients. Eur Respir J. 1999; 13: 103-106.
10. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbara MP, Gramiccioni E, Barnes PJ. Increased 8- isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002; 122: 1162-1167.
11. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Increased interleukin-4 and reduced interferon-in in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med. 2002; 165: 1290-1293.
12. Carpagnano GE, Resta O, Foscino-Brabar MP, Gramiccioni E, Carpagnano F. lnterleukin-6 is increased in the breath condensate of patients with non-small cell lung cancer. Int J Biol Markers. 2002; 17: 141-145.
13. Bucchioni E, Kharitonov SA, Allegra L, Barnes PL. High levels of interleukin-6 in the exhaled breath condensate in patients with COPD. Respir Med. 2003; 97: 1299-1302.
14. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J. 2003; 21: 589-593.
15. McRae K, De Perrot M, Fischer S, Waddell TK, Liu M, Keshavjee S. Detection of IL-10 in the exhaled breath condensate, plasma and tissue during ischemia reperfusion injury in experimental lung transplantation. J Heart Lung Transplant. 2001; 20: 184.
16. Shi T, Su D, Liu T, Tang K, Camp DG, Qian WJ, Smith RD. Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics. Proteomics. 2012; 12(8): 1074-1092.
17. Brand J, Haslberger T, Zolg W, Pestlin G, Palme S. Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column. Proteomics. 2006; 6(11): 3236-3242.